Free Trial

Wells Fargo & Company Increases Hamilton Lane (NASDAQ:HLNE) Price Target to $166.00

Hamilton Lane logo with Finance background

Hamilton Lane (NASDAQ:HLNE - Get Free Report) had its price objective lifted by equities research analysts at Wells Fargo & Company from $147.00 to $166.00 in a research note issued on Friday,Benzinga reports. The firm presently has an "equal weight" rating on the stock. Wells Fargo & Company's target price would suggest a potential downside of 0.05% from the company's current price.

A number of other brokerages have also recently issued reports on HLNE. Oppenheimer cut Hamilton Lane from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 15th. JPMorgan Chase & Co. dropped their price target on Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating for the company in a report on Tuesday, April 29th. Morgan Stanley reduced their price target on Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating on the stock in a research report on Monday, April 14th. Finally, Keefe, Bruyette & Woods raised their target price on shares of Hamilton Lane from $158.00 to $168.00 and gave the company a "market perform" rating in a report on Wednesday, February 5th. One analyst has rated the stock with a sell rating and six have given a hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $166.86.

Get Our Latest Analysis on HLNE

Hamilton Lane Trading Up 1.4%

Shares of Hamilton Lane stock traded up $2.23 during trading hours on Friday, hitting $166.09. The company's stock had a trading volume of 122,747 shares, compared to its average volume of 437,986. The stock has a 50 day moving average of $151.23 and a 200 day moving average of $159.52. Hamilton Lane has a 12 month low of $114.85 and a 12 month high of $203.72. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.19 and a quick ratio of 4.19. The company has a market capitalization of $9.21 billion, a PE ratio of 30.64 and a beta of 1.31.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Hamilton Lane by 252.0% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 176 shares of the company's stock valued at $26,000 after purchasing an additional 126 shares during the last quarter. WPG Advisers LLC bought a new stake in Hamilton Lane in the first quarter worth approximately $26,000. Versant Capital Management Inc acquired a new position in Hamilton Lane in the first quarter valued at approximately $30,000. Whittier Trust Co. of Nevada Inc. bought a new position in shares of Hamilton Lane during the 1st quarter worth approximately $33,000. Finally, CBIZ Investment Advisory Services LLC grew its position in shares of Hamilton Lane by 27.0% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 287 shares of the company's stock worth $43,000 after buying an additional 61 shares during the period. 97.40% of the stock is owned by institutional investors and hedge funds.

Hamilton Lane Company Profile

(Get Free Report)

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.

Featured Stories

Analyst Recommendations for Hamilton Lane (NASDAQ:HLNE)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hamilton Lane Right Now?

Before you consider Hamilton Lane, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.

While Hamilton Lane currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock
The Hottest AI Stock You Haven’t Bought Yet

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines